Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH).
about
Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Discovery of Tropifexor (LJN45 ...... oholic Steatohepatitis (NASH).
@en
Discovery of Tropifexor (LJN45 ...... oholic Steatohepatitis (NASH).
@nl
type
label
Discovery of Tropifexor (LJN45 ...... oholic Steatohepatitis (NASH).
@en
Discovery of Tropifexor (LJN45 ...... oholic Steatohepatitis (NASH).
@nl
prefLabel
Discovery of Tropifexor (LJN45 ...... oholic Steatohepatitis (NASH).
@en
Discovery of Tropifexor (LJN45 ...... oholic Steatohepatitis (NASH).
@nl
P2093
P50
P1476
Discovery of Tropifexor (LJN45 ...... oholic Steatohepatitis (NASH).
@en
P2093
Agnès Vidal
Andrew Phimister
Badry Bursulaya
Bryan Laffitte
Daniel Mutnick
Dingjiu Bao
Donatella Chianelli
H Martin Seidel
James Schmeits
P304
P356
10.1021/ACS.JMEDCHEM.7B00907
P407
P577
2017-11-16T00:00:00Z